Inhibition of enkephalin degradation attenuated stress-induced motor suppression (conditioned suppression of motility)

Toshitaka Nabeshima, A. Katoh, T. Kameyama

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Mice exhibit a marked suppression of motility when they are placed in the same cage in which they had previously received an electric shock. This suppression of motility is believed to be stress-induced and is a conditioned response. A decrease in the Met-enkephalin levels and a decrease in the dopamine (DA) turnover in the striatum of these 'conditioned suppression' groups have been exhibited. The present study investigates whether inhibition of enkephalin degradation induced by an enkephalinase A and/or aminopeptidase inhibitor attenuates a conditioned suppression of motility. The effects of thiorphan and bestatin, both alone and in combination, were investigated. Thiorphan alone (25, 50 and 100 μg i.c.v.) significantly attenuated the conditioned suppression of motility in a dose-dependent manner, but not bestatin (25, 50 and 100 μg i.c.v.) alone. The combination of these drugs (25 and 50 μg, each, i.c.v.) also significantly reduced the conditioned suppression of motility in a dose-dependent manner. The attenuation of conditioned suppression of motility induced by thiorphan and bestatin was antagonized by naloxone (5 mg/kg s.c.) and pimozide (100 μg/kg i.p.). In addition, the combination of thiorphan and bestatin reversed the decreases of Met-enkephalin levels and the decreases of DA turnover in the striatum in conditioned suppression group. These results suggest that attenuation of the conditioned suppression of motility induced by thiorphan and bestatin may be directly proportional to the increases of endogenous opioid peptide contents, and that the effect of these drugs may be related to the striatal DAergic system.

Original languageEnglish
Pages (from-to)303-309
Number of pages7
JournalJournal of Pharmacology and Experimental Therapeutics
Volume244
Issue number1
Publication statusPublished - 01-01-1988
Externally publishedYes

Fingerprint

Thiorphan
Enkephalins
Methionine Enkephalin
Dopamine
Pimozide
Corpus Striatum
Neprilysin
Aminopeptidases
Opioid Peptides
Drug Combinations
Naloxone
Shock
ubenimex
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

@article{c0f821fbacf140af8d0fc90983a5be7e,
title = "Inhibition of enkephalin degradation attenuated stress-induced motor suppression (conditioned suppression of motility)",
abstract = "Mice exhibit a marked suppression of motility when they are placed in the same cage in which they had previously received an electric shock. This suppression of motility is believed to be stress-induced and is a conditioned response. A decrease in the Met-enkephalin levels and a decrease in the dopamine (DA) turnover in the striatum of these 'conditioned suppression' groups have been exhibited. The present study investigates whether inhibition of enkephalin degradation induced by an enkephalinase A and/or aminopeptidase inhibitor attenuates a conditioned suppression of motility. The effects of thiorphan and bestatin, both alone and in combination, were investigated. Thiorphan alone (25, 50 and 100 μg i.c.v.) significantly attenuated the conditioned suppression of motility in a dose-dependent manner, but not bestatin (25, 50 and 100 μg i.c.v.) alone. The combination of these drugs (25 and 50 μg, each, i.c.v.) also significantly reduced the conditioned suppression of motility in a dose-dependent manner. The attenuation of conditioned suppression of motility induced by thiorphan and bestatin was antagonized by naloxone (5 mg/kg s.c.) and pimozide (100 μg/kg i.p.). In addition, the combination of thiorphan and bestatin reversed the decreases of Met-enkephalin levels and the decreases of DA turnover in the striatum in conditioned suppression group. These results suggest that attenuation of the conditioned suppression of motility induced by thiorphan and bestatin may be directly proportional to the increases of endogenous opioid peptide contents, and that the effect of these drugs may be related to the striatal DAergic system.",
author = "Toshitaka Nabeshima and A. Katoh and T. Kameyama",
year = "1988",
month = "1",
day = "1",
language = "English",
volume = "244",
pages = "303--309",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - Inhibition of enkephalin degradation attenuated stress-induced motor suppression (conditioned suppression of motility)

AU - Nabeshima, Toshitaka

AU - Katoh, A.

AU - Kameyama, T.

PY - 1988/1/1

Y1 - 1988/1/1

N2 - Mice exhibit a marked suppression of motility when they are placed in the same cage in which they had previously received an electric shock. This suppression of motility is believed to be stress-induced and is a conditioned response. A decrease in the Met-enkephalin levels and a decrease in the dopamine (DA) turnover in the striatum of these 'conditioned suppression' groups have been exhibited. The present study investigates whether inhibition of enkephalin degradation induced by an enkephalinase A and/or aminopeptidase inhibitor attenuates a conditioned suppression of motility. The effects of thiorphan and bestatin, both alone and in combination, were investigated. Thiorphan alone (25, 50 and 100 μg i.c.v.) significantly attenuated the conditioned suppression of motility in a dose-dependent manner, but not bestatin (25, 50 and 100 μg i.c.v.) alone. The combination of these drugs (25 and 50 μg, each, i.c.v.) also significantly reduced the conditioned suppression of motility in a dose-dependent manner. The attenuation of conditioned suppression of motility induced by thiorphan and bestatin was antagonized by naloxone (5 mg/kg s.c.) and pimozide (100 μg/kg i.p.). In addition, the combination of thiorphan and bestatin reversed the decreases of Met-enkephalin levels and the decreases of DA turnover in the striatum in conditioned suppression group. These results suggest that attenuation of the conditioned suppression of motility induced by thiorphan and bestatin may be directly proportional to the increases of endogenous opioid peptide contents, and that the effect of these drugs may be related to the striatal DAergic system.

AB - Mice exhibit a marked suppression of motility when they are placed in the same cage in which they had previously received an electric shock. This suppression of motility is believed to be stress-induced and is a conditioned response. A decrease in the Met-enkephalin levels and a decrease in the dopamine (DA) turnover in the striatum of these 'conditioned suppression' groups have been exhibited. The present study investigates whether inhibition of enkephalin degradation induced by an enkephalinase A and/or aminopeptidase inhibitor attenuates a conditioned suppression of motility. The effects of thiorphan and bestatin, both alone and in combination, were investigated. Thiorphan alone (25, 50 and 100 μg i.c.v.) significantly attenuated the conditioned suppression of motility in a dose-dependent manner, but not bestatin (25, 50 and 100 μg i.c.v.) alone. The combination of these drugs (25 and 50 μg, each, i.c.v.) also significantly reduced the conditioned suppression of motility in a dose-dependent manner. The attenuation of conditioned suppression of motility induced by thiorphan and bestatin was antagonized by naloxone (5 mg/kg s.c.) and pimozide (100 μg/kg i.p.). In addition, the combination of thiorphan and bestatin reversed the decreases of Met-enkephalin levels and the decreases of DA turnover in the striatum in conditioned suppression group. These results suggest that attenuation of the conditioned suppression of motility induced by thiorphan and bestatin may be directly proportional to the increases of endogenous opioid peptide contents, and that the effect of these drugs may be related to the striatal DAergic system.

UR - http://www.scopus.com/inward/record.url?scp=0023931471&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023931471&partnerID=8YFLogxK

M3 - Article

VL - 244

SP - 303

EP - 309

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 1

ER -